fda warning letter glp-1 solution september 9 2025 Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide Retatrutide Warning: What GLP-1 Providers

REDEFINE 2 showed 13.7% in T2D patients at 68 weeks

Compounded drugs are made by pharmacists to tailor a medication to a patient or if some drugs are in short supply

Clinical indications include deficiency due to inadequate diet or malabsorption, drug-induced deficiency (for example, from long-term isoniazid or oral contraceptives), and certain inborn errors of metabolism (such as pyridoxine-dependent seizures or sideroblastic anemia)

Fu LJ, Chen SB, Han LS, Guo Y, Zhao PJ, Zhu M, et al

Injectable formulations require prescriber oversight

However, you may also experience serious side effects, and you will likely have to keep taking the drug forever because youre not addressing any of the underlying causes behind your weight gain or weight loss resistance